Hi, it is not the product that has failed, it is the double blind trial because people failed to follow the protocol.
There is inherently nothing wrong with the product. We just need to conduct the correct trial whilst ensuring that the protocol is adhered to.
look at current price b4 saying anything, page-46
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #